The agency recognized the medication as a significant advancement for the treatment of IPF.
EMA Grants Bersiporocin Orphan Drug Designation
Posted on by admin
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
1 min read
The agency recognized the medication as a significant advancement for the treatment of IPF.
+ There are no comments
Add yours